Correction to: Laboratory Investigation
Published online 11 April 2019
The authors would like to apologize for the following errors in this paper:
The word “creactine” should be “creatinine” in Fig. 3c.
The term “mg/dl” should be “µmol/L” in Fig. 3c, d.
The first acknowledgement should read, “This work was supported by the National Natural Science Foundation of China (No. 81673792, 81704134, 81600624, 81800612, U1801288, and 81873346)…”
The address for Zhaozhong Xu should be Department of Nephrology, Zhujiang Hospital, Southern Medical University, 510280 Guangzhou, China.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Peng, F., Li, H., Li, S. et al. Correction: Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway. Lab Invest 100, 786–787 (2020). https://doi.org/10.1038/s41374-019-0301-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41374-019-0301-2
This article is cited by
-
Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis
Journal of Translational Medicine (2023)